Type II Diabetes
Conditions
Keywords
Diabetes, Compliance, Statin, Education
Brief summary
The objective of the study is to measure changes in compliance to statin therapy in patients with type 2 diabetes after an educational intervention. This intervention is part of the therapeutic education of the diabetic patient, carried out throughout the follow-up of his/her diabetes.
Interventions
Patients will follow a therapeutic education in order to inform them about the mechanism of action of statins. After this intervention a questionnaire will use to measure compliance.
Sponsors
Study design
Eligibility
Inclusion criteria
* 18 years old or more * Type 2 diabetes * Following treatment with statins * Hospitalization in the diabetes day hospitals of the Saint Philibert or Saint Vincent Hospitals (Lille, France). * Ability to answer the Girerd test in both interviews (in the individual interview and by phone) * Patient informed to participate in the study * Signed patient's consent.
Exclusion criteria
* Patients under guardianship
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Compliance rate to the statin treatment | 3 months | Compliance is estimated with the compliance evaluation Test of Girerd based on a score from 0 to 6. Six questions are asked to the patient. For the interpretation of the test: Total YES = 0, Score = 0: Good compliance Total YES = 1 or 2, Score = 1 or 2: Minimal compliance Total YES ≥ 3, Score ≥ 3: Poor compliance Lack of completion of the questionnaire is considered as poor compliance. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Compliance rate to the statin treatment according to schedule of drug intake | 3 months | Compliance is estimated with the compliance evaluation Test of Girerd based on a score from 0 to 6. Six questions are asked to the patient. For the interpretation of the test: Total YES = 0, Score = 0: Good compliance Total YES = 1 or 2, Score = 1 or 2: Minimal compliance Total YES ≥ 3, Score ≥ 3: Poor compliance Lack of completion of the questionnaire is considered as poor compliance. |
| Compliance rate to the statin treatment according to treatment duration. | 3 months | Compliance is estimated with the compliance evaluation Test of Girerd based on a score from 0 to 6. Six questions are asked to the patient. For the interpretation of the test: Total YES = 0, Score = 0: Good compliance Total YES = 1 or 2, Score = 1 or 2: Minimal compliance Total YES ≥ 3, Score ≥ 3: Poor compliance Lack of completion of the questionnaire is considered as poor compliance. |
Countries
France